Using and Referencing ISO and IEC Standards for Technical Regulation

Size: px
Start display at page:

Download "Using and Referencing ISO and IEC Standards for Technical Regulation"

Transcription

1 Using and Referencing ISO and IEC Standards for Technical Regulation Third ANSI Conference on U.S. Leadership in ISO and IEC May 23-24, 24, 2007 Chicago, IL David P. Kelly, M.I.M. Office of International Programs Office of the Commissioner U.S. Food and Drug Administration

2 Overview U.S. government use of standards Brief overview of the U.S. Food and Drug Administration FDA use of standards FDA s s new Staff Manual Guide and Standards Committee Benefits of using voluntary consensus standards FDA policy issues regarding voluntary consensus standards

3 U.S. Government Use of Standards National Technology Transfer and Advancement Act (NTTAA; PL ) 113) OMB directive (OMB A-119) A Interagency Committee on Standards Policy (ICSP) more info at m. Annual Report on Federal Agency Use of Voluntary Consensus Standards and Conformity Assessment produced by National Institute of Standards and Technology (NIST)

4 Brief Overview of FDA FDA s s mission, simply stated, is to: promote and protect the public health by helping safe and effective products reach the market in a timely way; monitor products for continued safety after they are in use; and help the public get the accurate, science- based information needed to improve health.

5 Brief Overview of FDA Wide array of products - From common food ingredients to complex medical devices, lifesaving drugs, and radiation-emitting consumer and medical products. $1 trillion a year - FDA FDA-regulated products account for about 25 cents of every consumer dollar spent. Variety of approaches New drugs and complex medical devices must be proven safe and effective before companies can market them. Other products, such as x-ray x machines and microwave ovens, must measure up to performance standards. And some products, such as cosmetics and dietary supplements, can be marketed with no prior approval.

6 Brief Overview of FDA Science-based, efficient risk management allows FDA to provide the most health promotion and protection at the least cost to the public. No regulated product is totally risk-free, so these judgments are important. FDA will allow a product to present more of a risk when its potential benefit is great -- especially for products used to treat serious, life-threatening conditions.

7 Brief Overview of FDA FDA uses regulations and product standards as the "yardsticks" that define specific requirements manufacturers must follow to assure product safety and to provide accurate information to health professionals and consumers.

8 FDA Use of Standards 21 CFR 10.95, Participation in outside standard-setting setting activities FDA Policy on Standards ( Policy( regarding the development and use of standards with respect to international harmonization of regulatory requirements and guidelines,, 60 FR (Oct. 11, 1995).

9 FDA Use of Standards FDA Centers use voluntary consensus standards to varying degrees, depending on the product and regulatory approach FDA Center experts actively participate in dozens of standards organizations Each Center may have a preferred standards forum depending on history, statutory requirements and experience

10 FDA Use of Standards Medical Devices The Center for Devices and Radiological Health (CDRH) has recognized nearly 800 standards over 200 from ISO and 70 from IEC arguably more than any other medical device regulatory authority CDRH standards database at h/cfdocs/cfstandards/search.cfm,, last updated on May 21, 2007 CDRH has also issued Recognition and Use of Consensus Standards; Final Guidance for Industry and FDA Staff, June 20, 2001

11 FDA Use of Standards Foods and Cosmetics The Center for Food Safety and Nutrition (CFSAN) actively participates in Codex Alimentarius Commission (CODEX) committees Code of Federal Regulations Title 21, Part 130, Subpart A, Sec requires that all food standards adopted by CODEX are to be reviewed by FDA CFSAN also participates in dozens of standards organizations

12 FDA Use of Standards Human Drugs The Center for Drug Evaluation and Research (CDER) participates more than a dozen standards organizations The Federal Food, Drug, And Cosmetic Act, Chapter V - Drugs And Devices, subchapter A, sec. 501 recognizes use of United States Pharmacopeia standards

13 FDA Use of Standards Biologics and Veterinary Products The Center for Biologics Evaluation and Research (CBER) and the Center for Veterinary Medicine (CVM) also participate in a variety of standards organizations

14 FDA s s New Staff Manual Guide and Standards Committee Staff Manual Guide adopted in March 2007 Purpose is to establish Agency-wide policies and procedures related to standards management to assure a unified approach to standards within FDA FDA formed a Standards Committee with representatives from all Centers to communicate about standards issues and carry out standards policy

15 Benefits of Using Voluntary Consensus Standards Greater potential to save time and money over FDA development of technical standards Open participation by affected parties Often represents leading-edge edge thinking on an issue Can lead to international harmonization on issues

16 FDA Policy Issues Regarding Voluntary Consensus Standards Forum shopping and protection by standards-development development organizations (SDOs) of their territory Normative references in standards World Trade Organization definition of a voluntary consensus standards body Government agencies retain the authority to set requirements Government agencies reserve the right to select standards

17 Conclusions FDA experts participate in dozens of standards committees This is a significant investment of resources in voluntary consensus standards development FDA receives much benefit from participating in voluntary consensus standards The SMG and Standards Committee will help FDA coordinate standards participation and usage across the Agency

18 Contact Information David P. Kelly, M.I.M. Associate Director for Harmonization, Europe, Trade Office of International Programs, Office of the Commissioner U.S. Food and Drug Administration Phone:

Residual Solvents: FDA/ Regulatory Perspective

Residual Solvents: FDA/ Regulatory Perspective Rosa Motta Compliance Officer Residual Solvents: FDA/ Regulatory Perspective PDA/USP Residual Solvents Conference January 18-19, 2007 1 Outline Laws and regulations governing the compliance requirements

More information

4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch

4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch Libia Lugo Drug Specialist San Juan District Office Investigations Branch The Food and Drug Administration (FDA) responsibilities extend to the 50 United States, the District of Columbia, Puerto Rico,

More information

Overview of Regulatory Science of Food Contact Substances

Overview of Regulatory Science of Food Contact Substances Overview of Regulatory Science of Food Contact Substances Michael A. Adams, PhD Deputy Director, Office of Food Additive Safety FDA, Center for Food Safety and Applied Nutrition 5001 Campus Drive, College

More information

Use of Standards in Substantial Equivalence Determinations

Use of Standards in Substantial Equivalence Determinations Guidance for Industry and for FDA Staff Use of Standards in Substantial Equivalence Determinations Document issued on: March 12, 2000 U.S. Department Of Health And Human Services Food and Drug Administration

More information

Draft Guidance for Industry and FDA Staff

Draft Guidance for Industry and FDA Staff Draft Guidance for Industry and FDA Staff Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile DRAFT GUIDANCE This guidance document

More information

Regulatory Submission Strategies and Outlines For Ultrasonic Surgical Devices: Contact and HIFU Systems UIA Symposium Ronald R.

Regulatory Submission Strategies and Outlines For Ultrasonic Surgical Devices: Contact and HIFU Systems UIA Symposium Ronald R. Regulatory Submission Strategies and Outlines For Ultrasonic Surgical Devices: Contact and HIFU Systems 2006 UIA Symposium Ronald R. Manna Regulation Governing Medical Devices Europe: Council Directive

More information

Political Economy of the Medical Products Industry

Political Economy of the Medical Products Industry Political Economy of the Medical Products Industry Tom Hazlet Survey of Biomedical Regulatory Affairs Spring 2008 Menu Definitions medical products political economy Commodities drugs devices biologics

More information

January 7, Dear Ms. Chung:

January 7, Dear Ms. Chung: DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 January 7, 2015 Jeisys

More information

FDA Sampling Guidance and Practices. Terri McConnell FDA/ORA/Office of Regulatory Science

FDA Sampling Guidance and Practices. Terri McConnell FDA/ORA/Office of Regulatory Science FDA Sampling Guidance and Practices Terri McConnell FDA/ORA/Office of Regulatory Science Background and General Information Mission of the Food and Drug Administration (FDA) Major Laws Enforced by the

More information

Responsibilities of Laser Light Show Projector Manufacturers, Dealers, and Distributors; Final Guidance for Industry and FDA.

Responsibilities of Laser Light Show Projector Manufacturers, Dealers, and Distributors; Final Guidance for Industry and FDA. Responsibilities of Laser Light Show Projector Manufacturers, Dealers, and Distributors; Final Guidance for Industry and FDA (Laser Notice 51) Document issued on: May 27, 2001 U.S. Department of Health

More information

FDA 510(k) 101 The Basics

FDA 510(k) 101 The Basics FDA 510(k) 101 The Basics Floyd G. Larson President, PaxMed International San Diego, CA OMTEC June 17, 2010 Chicago Agenda History of 510(k) process FDA s risk based approach FDA guidance and standards

More information

Ko0 -t. Exhibit 2 MAY 3 0? 510 (K) Summay. Company Name: Columbia Scientific Development, LLC 420 NW I Ith Ave., Suite 617 Portland, Oregon 97209

Ko0 -t. Exhibit 2 MAY 3 0? 510 (K) Summay. Company Name: Columbia Scientific Development, LLC 420 NW I Ith Ave., Suite 617 Portland, Oregon 97209 Ko0 -t Exhibit 2 MAY 3 0? 510 (K) Summay Company Name: Columbia Scientific Development, LLC 420 NW I Ith Ave., Suite 617 Portland, Oregon 97209 Contact: Stephen Shulman Phone: 734-663-0132 Fax: 734-663-1306

More information

Re: National Bioengineered Food Disclosure Standard; Proposed Rule; Request for Comments, 83 Fed. Reg (May 4, 2018), Docket No.

Re: National Bioengineered Food Disclosure Standard; Proposed Rule; Request for Comments, 83 Fed. Reg (May 4, 2018), Docket No. VIA ELECTRONIC SUBMISSION July 3, 2018 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: National Bioengineered Food Disclosure Standard;

More information

Module 34: Legal aspects, ADI and GRAS status of food additives

Module 34: Legal aspects, ADI and GRAS status of food additives Paper No.: 13 Paper Title: FOOD ADDITIVES Module 34: Legal aspects, ADI and GRAS status of food additives 34.1 Legal Aspects of Food Additives The data provided by Joint Expert Committee on Food Additives

More information

Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA

Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA Document issued on: November 12, 2002 This document supersedes the

More information

FDA Basics FDA s Import Operations: How FDA Regulates Imported Products

FDA Basics FDA s Import Operations: How FDA Regulates Imported Products FDA Basics FDA s Import Operations: How FDA Regulates Imported Products Carlos W. Hernandez Compliance Officer U.S. Food and Drug Administration Global Regulatory Operations and Policy Office of Regulatory

More information

March 8, DxNow, Inc. Kevin Sly Senior Advisor to DxNow, Inc. 401 Professional Drive, Suite 130 Gaithersburg, Maryland

March 8, DxNow, Inc. Kevin Sly Senior Advisor to DxNow, Inc. 401 Professional Drive, Suite 130 Gaithersburg, Maryland March 8, 2018 Kevin Sly Senior Advisor to 401 Professional Drive, Suite 130 Gaithersburg, Maryland 20879-3429 Re: Trade/Device Name: ZyMot ICSI Sperm Separation Device, ZyMot Multi Sperm Separation Device

More information

510(k) 21 Summary of Safety and Effectiveness

510(k) 21 Summary of Safety and Effectiveness 510(k) 21 Summary of Safety and Effectiveness This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirement of 21 CFR 807.92. Submitter's Identification:

More information

(Cochineal Extract and Carmine: Declaration by Name on the Label of All Foods and Cosmetic Products That Contain These Color Additives)

(Cochineal Extract and Carmine: Declaration by Name on the Label of All Foods and Cosmetic Products That Contain These Color Additives) ก ก 2553 ก : ก (Cochineal Extract and Carmine: Declaration by Name on the Label of All Foods and Cosmetic Products That Contain These Color Additives) : ก ก ก : ก ก ก : 2552 : 2552 1 ก 5 ก : ก (Cochineal

More information

Agency Information Collection Activities; Submission for Office of Management and

Agency Information Collection Activities; Submission for Office of Management and This document is scheduled to be published in the Federal Register on 03/04/2019 and available online at https://federalregister.gov/d/2019-03824, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND

More information

Agency Information Collection Activities; Submission for Office of Management and Budget

Agency Information Collection Activities; Submission for Office of Management and Budget This document is scheduled to be published in the Federal Register on 01/28/2016 and available online at http://federalregister.gov/a/2016-01690, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION

UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION Citizen Petition to: Margaret A. Hamburg, M.D, Commissioner of Food and Drugs Docket No. For Review of Standard of Identity

More information

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 4. Intro ISO GMP - GLP Pierre-Alain Sommer

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 4. Intro ISO GMP - GLP Pierre-Alain Sommer Nano-Tera.ch 05 February 2015 part 4 Intro ISO GMP - GLP Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 Introduction to ISO 13485, cgmp s and GLP s Context

More information

Mary Frances Lowe U.S. Codex Office World Spices Congress Kochi, India February 16-19, 2014

Mary Frances Lowe U.S. Codex Office World Spices Congress Kochi, India February 16-19, 2014 Mary Frances Lowe U.S. Codex Office World Spices Congress Kochi, India February 16-19, 2014 1 What is the Codex Alimentarius Relationship between Codex and WTO Agreements Principles and Values International

More information

CFSAN Update Michael M. Landa

CFSAN Update Michael M. Landa CFSAN Update Comments by Michael M. Landa Director, Center for Food Safety and Applied Nutrition JIFSAN Fall Advisory Council Meeting November 14, 2013 1 CFSAN Plan for Program Priorities (2013 2014) Reduce

More information

July 10, X-spine Systems, Incorporated David Kirschman, MD Chief Medical Officer 452 Alexandersville Road Miamisburg, Ohio 45342

July 10, X-spine Systems, Incorporated David Kirschman, MD Chief Medical Officer 452 Alexandersville Road Miamisburg, Ohio 45342 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service July 10, 2015 Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 X-spine

More information

Global Regulation of Food Additives

Global Regulation of Food Additives Chapter 1 Global Regulation of Food Additives Downloaded via 148.251.232.83 on January 28, 2019 at 18:43:58 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published

More information

Perspective from HHS Offices and Programs on Women s s Health: FDA Perspective

Perspective from HHS Offices and Programs on Women s s Health: FDA Perspective Perspective from HHS Offices and Programs on Women s s Health: FDA Perspective Kathleen Uhl, MD Assistant Commissioner for Women s s Health Office of Women s Health IOM Committee on Women s s Health Research

More information

NEURONETICS. 510(k) SUMMARY NEUROSTAR TMS THERAPY SYSTEM'

NEURONETICS. 510(k) SUMMARY NEUROSTAR TMS THERAPY SYSTEM' NEURONETICS 510(k) SUMMARY NEUROSTAR TMS THERAPY SYSTEM' 510(k) Owner: Neuronetics, Inc. DEC 1 6 Z008 1 Great Valley Parkway, Suite 2 Malvern, PA 19355 Phone: 610-640-4202 Fax: 610-640-4206 Company Contact:

More information

General Wellness: Policy for Low Risk Devices Guidance for Industry and Food and Drug Administration Staff

General Wellness: Policy for Low Risk Devices Guidance for Industry and Food and Drug Administration Staff General Wellness: Policy for Low Risk Devices Guidance for Industry and Food and Drug Administration Staff Document issued on: July 29, 2016. The draft of this document was issued on January 20, 2015.

More information

5101K] SUMMARY [as required by (c)]

5101K] SUMMARY [as required by (c)] 735-10, Ancheong-dong, Gwangsan-gu, Gwangju, Korea FAX:+82-62-954-1055 http://www. inarex. co. kr IN AR E)( TEL:+82-62-952-1052 INAREX CORPORATION 5101K] SUMMARY [as required by 807.92(c)] AUG 2 7 2008

More information

Purpose of this Document

Purpose of this Document Guidance on the Procedures for Joint Food Safety and Inspection Service (FSIS) and Food and Drug Administration (FDA) Approval of Ingredients and Sources of Radiation Used in the Production of Meat and

More information

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS SEPTEMBER 23, 2009 COUNCIL OF THE CONVENTION SECTION ON THE QUALITY OF FOOD INGREDIENTS AND DIETARY SUPPLEMENTS INTRODUCTION The 1994 Dietary Supplement

More information

Integrating the Broader Public Health Consequences of Opioid Abuse and Misuse into the Evaluation of New Opioid Products

Integrating the Broader Public Health Consequences of Opioid Abuse and Misuse into the Evaluation of New Opioid Products Integrating the Broader Public Health Consequences of Opioid Abuse and Misuse into the Evaluation of New Opioid Products Peter Lurie, MD, MPH Associate Commissioner Office of Public Health Strategy and

More information

February 15, AtriCure, Inc. Melissa Smallwood Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040

February 15, AtriCure, Inc. Melissa Smallwood Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040 February 15, 2018 AtriCure, Inc. Melissa Smallwood Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040 Re: K180137 Trade/Device Name: AtriCure cryoice cryo-ablation probe (CRYO3), AtriCure

More information

Food Additives Program

Food Additives Program U.S. FDA s Food Additive Program: An Update on Resources and Challenges 18 th Food Packaging Law Seminar October 11, 2017 Arlington, VA 1 Food Additives Program Dennis Keefe, PhD Director, Office of Food

More information

GRAS Overview and Industry Perspectives. Janet Balson International Food Additives Council

GRAS Overview and Industry Perspectives. Janet Balson International Food Additives Council GRAS Overview and Industry Perspectives Janet Balson International Food Additives Council The International Food Additives Council (IFAC) IFAC is an international association, representing companies who

More information

FDA Laws & Pharmacy Practice

FDA Laws & Pharmacy Practice Objectives FDA Laws & Pharmacy Practice Tom Hazlet Pharmacy 543 October 6, 2004 Be able to discuss the evolution of food and drug law in the United States Be able to discuss the ways in which pharmacists

More information

FDA Laws & Pharmacy Practice

FDA Laws & Pharmacy Practice Objectives FDA Laws & Pharmacy Practice Tom Hazlet Pharmacy 543 Autumn 2006 Be able to discuss the evolution of food and drug law in the United States Be able to discuss the ways in which pharmacists and

More information

Amyotrophic Lateral Sclerosis: Developing Drugs for Treatment Guidance for Industry

Amyotrophic Lateral Sclerosis: Developing Drugs for Treatment Guidance for Industry Amyotrophic Lateral Sclerosis: Developing Drugs for Treatment Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding

More information

Border Issues and Statistics: Regulatory Activities. Mr. Robert Deininger Southwest Import Director AFDO San Antonio, Texas

Border Issues and Statistics: Regulatory Activities. Mr. Robert Deininger Southwest Import Director AFDO San Antonio, Texas Border Issues and Statistics: Regulatory Activities Mr. Robert Deininger Southwest Import Director AFDO San Antonio, Texas U.S. Food & Drug Administration Mission Statement The Food & Drug Administration

More information

Agenda. What we do. GMA - Overview 30,000. Public Private Partnerships in the Development of Food Safety Regulations. $415 billion

Agenda. What we do. GMA - Overview 30,000. Public Private Partnerships in the Development of Food Safety Regulations. $415 billion Agenda Public Private Partnerships in the Development of Food Safety Regulations Manojit Basu, PhD Senior Director, Product Safety and Regulatory Affairs, & Adjunct Professor, Johns Hopkins University

More information

NOV Jo 6) ' 510(k) Summary

NOV Jo 6) ' 510(k) Summary NOV 2 9 2004Jo 6) ' 510(k) Summary 1. Applicant Amest Corporation 303194 Espetranza Rancho Santa Margarita, CA 92688 Contact person: John Jest Amnest Corporation 30394 Espcranza Rancho Santa Margarita,

More information

A high-level overview of the requirements of medical packaging standards

A high-level overview of the requirements of medical packaging standards Medical Packaging A high-level overview of the requirements of medical packaging standards Dec 2012 Thierry Wagner Regulatory Affairs Director Europe, Middle East and Africa DuPont Medical & Pharmaceutical

More information

FDA s Food Additives Program

FDA s Food Additives Program FDA s Food Additives Program LaShonda T. Cureton, PhD Office of Food Additive Safety US Food and Drug Administration Food Additives: A Global Perspective on Safety Evaluation and Use Procedures for Approval

More information

SPINE. 510(k) Summary. Anterior/anterolateral noncervical use (KWQ) (Prodct Cde):Noncervical

SPINE. 510(k) Summary. Anterior/anterolateral noncervical use (KWQ) (Prodct Cde):Noncervical k10 3?I13 SPINE 510(k) Summary FB-22f FB 24f This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR 807.92. Preparation Date: November

More information

April 25, 2014 Reference No. HAMB FDA Transparency Initiative Regulations Development

April 25, 2014 Reference No. HAMB FDA Transparency Initiative Regulations Development Reference No. HAMB14001 Via Email Dr. Margaret Hamburg Commissioner U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 margaret.hamburg@fda.hhs.gov SUBJECT: FDA Transparency

More information

Donald W. Guthner Orgenix, LLC Ill Hill Road. Douglassville, PA (888) ORGENIX ( ) (484) (FAX) Intramedullary Nails, Nails

Donald W. Guthner Orgenix, LLC Ill Hill Road. Douglassville, PA (888) ORGENIX ( ) (484) (FAX) Intramedullary Nails, Nails K070741 ~, SANATMETAL Manufacturer of Orthopaedic and Traumatologic Products H-3301, Eger Faiskola ut 5. Phone: +(36)36-512-900 Fax: +(36)36-512-932 e-mail: metalasanatmetal.hu 510(k) Statement of Summary

More information

Definitions and technical criteria for food ingredients to be considered as natural

Definitions and technical criteria for food ingredients to be considered as natural TECHNICAL SPECIFICATION ISO/TS 19657 First edition 2017-12 Definitions and technical criteria for food ingredients to be considered as natural Définitions et critères techniques permettant de considérer

More information

Safety Evaluation for Substances Directly Added to Food

Safety Evaluation for Substances Directly Added to Food Safety Evaluation for Substances Directly Added to Food Teresa Croce, PhD Office of Food Additive Safety Center for Food Safety and Applied Nutrition US Food and Drug Administration How Does FDA Regulate

More information

FDA Food Safety Modernization Act (FSMA) January 4, 2011

FDA Food Safety Modernization Act (FSMA) January 4, 2011 FDA Food Safety Modernization Act (FSMA) January 4, 2011 FDA Food Safety Modernization Act (FSMA) The Most Sweeping Reform of the U.S. Food Safety Laws in More than 70 Years FDA Food Safety Modernization

More information

Addressing the Challenge of ENDS Regulation. David Graham President & Managing Partner Reveritas Group

Addressing the Challenge of ENDS Regulation. David Graham President & Managing Partner Reveritas Group Addressing the Challenge of ENDS Regulation David Graham President & Managing Partner Reveritas Group Addressing the Challenge of ENDS Regulation 1. The context of conflict and effect of the crossfire

More information

February 15, AtriCure, Inc. Melissa Smallwood Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040

February 15, AtriCure, Inc. Melissa Smallwood Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040 February 15, 2018 AtriCure, Inc. Melissa Smallwood Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040 Re: K180138 Trade/Device Name: AtriCure cryoice cryo-ablation probe (CRYO2) Regulation

More information

Instrument, Surgical, Powered, Laser 79-GEX 21I CFR878-48

Instrument, Surgical, Powered, Laser 79-GEX 21I CFR878-48 kor~f ¼ UL 2 62004 This 510(K) Summary of safety and effectiveness for the Millennium Dental Technologies PerioLase Dental Laser System is submitted in accordance with the requirements of the SMDA 1990

More information

Preparing a US FDA Medical Device 510(K) Submission

Preparing a US FDA Medical Device 510(K) Submission Preparing a US FDA Medical Device 510(K) Submission If you want to introduce your medical device to the US market, you need to obtain clearance from the FDA. This clearance is obtained from the FDA via

More information

THE OVERVIEW OF FOOD QUALITY

THE OVERVIEW OF FOOD QUALITY Handout MK. Pengawasan Mutu 2013/2014 THE OVERVIEW OF FOOD QUALITY Inneke Hantoro What is food quality? Food quality is the extent to which all the established requirements relating to the characteristics

More information

Codex Alimentarius and the US Dietary Supplement Industry. Mark A. Le Doux, Chairman and CEO Natural Alternatives International, Inc.

Codex Alimentarius and the US Dietary Supplement Industry. Mark A. Le Doux, Chairman and CEO Natural Alternatives International, Inc. Codex Alimentarius and the US Dietary Supplement Industry Mark A. Le Doux, Chairman and CEO Natural Alternatives International, Inc. UNDERSTANDING THE CODEX ALIMENTARIUS Since the first steps were taken

More information

510(k) SUMMARY STATEMEMT. Mettler Traction Device, MTD 4000 OCT Mettler Electronics Corp South Claudina Street Anaheim, CA 92805

510(k) SUMMARY STATEMEMT. Mettler Traction Device, MTD 4000 OCT Mettler Electronics Corp South Claudina Street Anaheim, CA 92805 510(k) SUMMARY STATEMEMT OCT - 8 2009 Mettler Traction Device, MTD 4000 Submitter's Name: Address: Mettler Electronics Corp. 1333 South Claudina Street Anaheim, CA 92805 Telephone: 714-533-2221 x324 Fax:

More information

Dear Cecilia Ceng: U.S. Food & Drug Administration New Hampshire Avenue Doc ID# Silver Spring, MD

Dear Cecilia Ceng: U.S. Food & Drug Administration New Hampshire Avenue Doc ID# Silver Spring, MD November 8, 2017 Cassie Lee Vice President Guangzhou GLOMED Biological Technology Co., Ltd. Suite 306, Kecheng Mansion, No.121 Science Road, Guangzhou Science Park Guangzhou, 510663 CN Re: K170229 Trade/Device

More information

BEFORE THE UNITED STATES OF AMERICA FOOD AND DRUG ADMINISTRATION COMMENTS OF THE AMERICAN HERBAL PRODUCTS ASSOCIATION

BEFORE THE UNITED STATES OF AMERICA FOOD AND DRUG ADMINISTRATION COMMENTS OF THE AMERICAN HERBAL PRODUCTS ASSOCIATION DOCKET NO. FDA 2017 N 5094 BEFORE THE UNITED STATES OF AMERICA FOOD AND DRUG ADMINISTRATION COMMENTS OF THE AMERICAN HERBAL PRODUCTS ASSOCIATION ON FDA s Request for Comments on Evaluation of Existing

More information

July 3, Re: Proposed Rule: National Bioengineered Food Disclosure Standard. 83 FR (May 4, 2018). Docket No. AMS-TM

July 3, Re: Proposed Rule: National Bioengineered Food Disclosure Standard. 83 FR (May 4, 2018). Docket No. AMS-TM July 3, 2018 VIA ELECTRONIC SUBMISSION Agricultural Marketing Service Docket Clerk 1400 Independence Ave. SW Room 4543-South Washington, DC 20250 Re: Proposed Rule: National Bioengineered Food Disclosure

More information

Engaging with FDA: A Guide for Foundation Funders of Research. FasterCures Webinar Series presents. April 18, 2012

Engaging with FDA: A Guide for Foundation Funders of Research. FasterCures Webinar Series presents. April 18, 2012 FasterCures Webinar Series presents Engaging with FDA: A Guide for Foundation Funders of Research April 18, 2012 Moderated by Margaret Anderson Executive Director, FasterCures Engaging with FDA: A Guide

More information

Bacterin International Incorporated Mr. Howard L. Schrayer 600 Cruiser Lane Belgrade, Montana August 18, 2015

Bacterin International Incorporated Mr. Howard L. Schrayer 600 Cruiser Lane Belgrade, Montana August 18, 2015 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 Bacterin International

More information

Mini Summit XIV: Clinical Trial Disclosure and Results Reporting Liability under FDAAA, Section 801

Mini Summit XIV: Clinical Trial Disclosure and Results Reporting Liability under FDAAA, Section 801 Mini Summit XIV: Clinical Trial Disclosure and Results Reporting Liability under FDAAA, Section 801 Jarilyn Dupont, JD Director of Regulatory Policy, Office of Policy Office of Commissioner, U.S. Food

More information

TELEMED. November 3, Engineering Manager Dariaus ir Gireno str. 42 Vilnius, LT LITHUANIA

TELEMED. November 3, Engineering Manager Dariaus ir Gireno str. 42 Vilnius, LT LITHUANIA DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 TELEMED Engineering Manager

More information

General Chapter/Section: <232> Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No.

General Chapter/Section: <232> Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No. General Chapter/Section: Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No. of Commenters: 18 Editorial changes suggested by commenters have been reviewed by

More information

FDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update

FDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update FDLI s Enforcement, Litigation, and Compliance Conference Center for Tobacco Products Office of Compliance and Enforcement 2017 Update Ann Simoneau, Director Office of Compliance and Enforcement Center

More information

510(k) Summary. Acumed, LLC 5885 NW Cornelius Pass Road Hillsboro, OR 97124

510(k) Summary. Acumed, LLC 5885 NW Cornelius Pass Road Hillsboro, OR 97124 K(102998 Page I of 2 510(k) Summary Device Trade Name: Congruent Bone Plate System J A.N 4 21 Manufacturer: Contact: Prepared by: Acumed, LLC 5885 NW Cornelius Pass Road Hillsboro, OR 97124 Mr. Ed Boehmer

More information

Introduction. Current status of 510(k) clinical data requirements. 1 Current Status&Considerations:

Introduction. Current status of 510(k) clinical data requirements. 1   Current Status&Considerations: 510(k) Current Status&Considerations: Conducting a Well-Controlled Clinical Study When Clinical Data is Required Introduction In an effort to promote innovation while protecting the population at large,

More information

Certification in the scope of Customs Union Russia Belarus Kazakhstan

Certification in the scope of Customs Union Russia Belarus Kazakhstan «Trade conditions with the Russian Federation» Certification in the scope of Customs Union Russia Belarus Kazakhstan Uliana Karpekina senior lawyer, head of commercial practice group September 16, 2010

More information

Advancing Use of Patient Preference Information as Scientific Evidence in Medical Product Evaluation Day 2

Advancing Use of Patient Preference Information as Scientific Evidence in Medical Product Evaluation Day 2 Advancing Use of Patient Preference Information as Scientific Evidence in Medical Product Evaluation Day 2 Theresa Mullin, PhD Director, Office of Strategic Programs FDA Center for Drug Evaluation and

More information

GROCERY MANUFACTURERS ASSOCIATION. Science Forum. Connecting Sound Science and Responsible Solutions

GROCERY MANUFACTURERS ASSOCIATION. Science Forum. Connecting Sound Science and Responsible Solutions GROCERY MANUFACTURERS ASSOCIATION Science Forum Connecting Sound Science and Responsible Solutions FSMA Implementation Michael M. Landa Director, Center for Food Safety and Applied Nutrition Food and Drug

More information

FDA Regulation of Claims on Dietary Supplement and Food Products

FDA Regulation of Claims on Dietary Supplement and Food Products FDA Regulation of Claims on Dietary Supplement and Food Products Patricia Kaeding August 2004 Topics FDA Overview What are claims Why claims matter Categories of claims Regulatory requirements for types

More information

O(K) SUMMARY. Mega'Gen Co., Ltd , Eupchun-Ri, Jain-Myun. Gyeongsan, Gyeongbuk South Korea Phone: , Fax:

O(K) SUMMARY. Mega'Gen Co., Ltd , Eupchun-Ri, Jain-Myun. Gyeongsan, Gyeongbuk South Korea Phone: , Fax: EZ PLUS IMPLANT SYSTEM 13. 510O(K) SUMMARY Mega'Gen Co., Ltd. 114-8, Eupchun-Ri, Jain-Myun. Gyeongsan, Gyeongbuk South Korea Phone: 82-53-857-5770, Fax: 82-53-857-5432 510(K) Summary 510O(K) SUMMARY AND

More information

December 4, 2017 VIA ELECTRONIC SUBMISSION

December 4, 2017 VIA ELECTRONIC SUBMISSION VIA ELECTRONIC SUBMISSION December 4, 2017 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Development of a List of pre-dietary Supplement

More information

Agenda: Dental Cone Beam Imaging

Agenda: Dental Cone Beam Imaging Cone Beam Imaging Agenda: Dental Cone Beam Imaging *Definition and Functionality *Usage and diagnostics benefits *Comparative radiation information *Federal regulatory responsibilities: manufacturing *State

More information

March 19, Dear Ms. Strohkirch:

March 19, Dear Ms. Strohkirch: DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service March 19, 2015 Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 Treace

More information

TOBACCO PRODUCT OR MEDICAL PRODUCT?

TOBACCO PRODUCT OR MEDICAL PRODUCT? TOBACCO PRODUCT OR MEDICAL PRODUCT? Priscilla Callahan-Lyon, MD Deputy Director Division of Individual Health Science Office of Science, CTP Grail Sipes, JD Director Office of Regulatory Policy, CDER Disclaimer:

More information

Over-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen

Over-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen Reprinted from FDA s website by EAS Consulting Group, LLC Over-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed

More information

ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry

ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments

More information

Ensuring protection of public health and patients in member states: priorities, constraints, opportunities

Ensuring protection of public health and patients in member states: priorities, constraints, opportunities Ensuring protection of public health and patients in member states: priorities, constraints, opportunities Dr. Christa Wirthumer-Hoche AGES Austrian Medicines and Medical Devices Agency Vienna, Austria

More information

BEST PRACTICE CHANGE CONTROL : DECIDING WHEN TO SUBMIT A 510(K) FOR A DEVICE CHANGE. Yuan Xu 18- JAN- 2018

BEST PRACTICE CHANGE CONTROL : DECIDING WHEN TO SUBMIT A 510(K) FOR A DEVICE CHANGE. Yuan Xu 18- JAN- 2018 BEST PRACTICE CHANGE CONTROL : DECIDING WHEN TO SUBMIT A 510(K) FOR A DEVICE CHANGE Yuan Xu 18- JAN- 2018 Background AGENDA What is Medical Device? What is 510(k)? Principles of best practices of device

More information

USP Perspective on Atypical Actives November 29, 2017

USP Perspective on Atypical Actives November 29, 2017 USP Perspective on Atypical Actives November 29, 2017 USP Excipients Stakeholder Forum USP Perspective on Atypical Actives Catherine Sheehan, M.S., M.S. Senior Director, Science Excipients Outline Role

More information

UALITY SYSTEMS STANDARDS

UALITY SYSTEMS STANDARDS UALITY SYSTEMS STANDARDS VICTOR DORMAN-SMITH ABBOTT IRELAND Singapore 2002/05/17 BASIC STANDARDS ISO 9001, 2 & 3:1994 ISO 9001:2000 EN 46001, 2 :1993 Revised in 1996 ISO 13485 & 8:1996 DIS 13485:2002 =(ISO

More information

510(K) SUMMARY. Ventus Medical, Inc Shoreway Road, Suite 340 Belmont, CA Menlo Park, CA (650) (phone) (650) (fax)

510(K) SUMMARY. Ventus Medical, Inc Shoreway Road, Suite 340 Belmont, CA Menlo Park, CA (650) (phone) (650) (fax) 510(K) SUMMARY 510(k) Applicant: Contact: Ventus Medical, Inc. 1301 Shoreway Road, Suite 340 Belmont, CA 94002 Menlo Park, CA 94025 (650) 632-4199 (phone) (650) 632-4198 (fax) Cindy Domecus, R.A.C. (US

More information

Comments of the Patient, Consumer, and Public Health Coalition. Strengthening the Center for Devices and Radiological Health s 510(k) Review Process

Comments of the Patient, Consumer, and Public Health Coalition. Strengthening the Center for Devices and Radiological Health s 510(k) Review Process March 19, 2010 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Comments of the Patient, Consumer, and Public Health Coalition on Strengthening

More information

FDA Oversight of Nanotechnology Applications in Foods, Food Packaging, and Nutrient Delivery

FDA Oversight of Nanotechnology Applications in Foods, Food Packaging, and Nutrient Delivery FDA Oversight of Nanotechnology Applications in Foods, Food Packaging, and Nutrient Delivery Laura M. Tarantino, Ph.D. Office of Food Additive Safety Center for Food Safety and Applied Nutrition (CFSAN)

More information

CDRH: 510(k)S AND SCIENCE IN REGULATOR DECISION-MAKING. lannery, Scott Danzis and Christopher Pruitt. November 2010 SPECIAL REPRINT

CDRH: 510(k)S AND SCIENCE IN REGULATOR DECISION-MAKING. lannery, Scott Danzis and Christopher Pruitt. November 2010 SPECIAL REPRINT November 2010 SPECIAL REPRINT CDRH: 510(k)S AND SCIENCE IN REGULATOR ORY DECISION-MAKING By Ellen Flanner lannery, Scott Danzis and Christopher Pruitt Reproduced with the kind permission of Global Regulatory

More information

MARKETING STANDARDS FOR MEMBERSHIP

MARKETING STANDARDS FOR MEMBERSHIP MARKETING STANDARDS FOR MEMBERSHIP The Vapor Technology Association (VTA) is a leading national trade association in the electronic cigarette and vapor product industry. VTA represents the manufacturers,

More information

ANDA Arthur P. Bedrosian, President Armenpharm, Ltd. 49 South Ridge Road P.O. Box D1400 Pomona, NY December 3, 2015

ANDA Arthur P. Bedrosian, President Armenpharm, Ltd. 49 South Ridge Road P.O. Box D1400 Pomona, NY December 3, 2015 DEPARTMENT OF HEALTH & HUMAN SERVICES Silver Spring, MD 20993 ANDA 060851 Arthur P. Bedrosian, President Armenpharm, Ltd. 49 South Ridge Road P.O. Box D1400 Pomona, NY 10970 Docket No. FDA-2011-P-0081

More information

International Pharmaceutical Aerosol Consortium on Regulation and Science

International Pharmaceutical Aerosol Consortium on Regulation and Science International Pharmaceutical Aerosol Consortium on Regulation and Science 1500 K Street NW Washington DC 20005 Telephone +1 202 230 5607 Fax +1 202 842 8465 Email info@ipacrs.org Web www.ipacrs.org Submitted

More information

Guidance for Industry

Guidance for Industry Reprinted from FDA s website by Guidance for Industry Bar Code Label Requirements Questions and Answers (Question 12 Update) DRAFT GUIDANCE This guidance document is for comment purposes only. Submit comments

More information

RECALL / EVENT INVESTIGATION & PATIENT LOOK BACK

RECALL / EVENT INVESTIGATION & PATIENT LOOK BACK RECALL / EVENT INVESTIGATION & PATIENT LOOK BACK Federal, State and AABB requirements for nonconforming product investigation and recipient look back for adverse impact Stacy Ralston MPH, CLS (ASCP), RAC

More information

GRAS Overview and Industry Perspectives. Priscilla Zawislak Ashland, Inc. International Food Additives Council

GRAS Overview and Industry Perspectives. Priscilla Zawislak Ashland, Inc. International Food Additives Council GRAS Overview and Industry Perspectives Priscilla Zawislak Ashland, Inc. International Food Additives Council IFAC Background The International Food Additives Council (IFAC) is a global association representing

More information

Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public Hearing;

Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public Hearing; 4160-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 15 [Docket No. FDA-2013-N-0402] Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public

More information

FDA Foods Program Update

FDA Foods Program Update FDA Foods Program Update Comments by Stephen F. Sundlof, D.V.M., Ph.D. Director Center for Food Safety and Applied Nutrition JIFSAN Annual Meeting, College Park, MD March 25, 2010 The Food Safety Working

More information

USP Probiotics Program

USP Probiotics Program USP Dietary Supplements Stakeholder Forum Tuesday, May 15, 2018 USP Probiotics Program Mike Bradley, Ph.D. Member USP Probiotic Expert Panel Member USP Non-Botanical Dietary Supplement Expert Committee

More information

Contact [UlS agent: Dong Guk Ha. April Lee MegaGenImplant Co., Ltd.

Contact [UlS agent: Dong Guk Ha. April Lee MegaGenImplant Co., Ltd. 5 10kW Submission Xeed PAnyffide Internal Imlant System MAR 2 7 2013 510(k) Summary This summary of 510(k) safety and effectiveness information is being submitted in accordance with requirements of 21

More information

U. AUG skeletal dynamics. 510(k) Summary of Safety and Effectiveness Skeletal Dynamics Geminus Volar Distal Radius Plate System

U. AUG skeletal dynamics. 510(k) Summary of Safety and Effectiveness Skeletal Dynamics Geminus Volar Distal Radius Plate System U. AUG 23 2011 00 skeletal dynamics 510(k) Summary of Safety and Effectiveness Skeletal Dynamics Geminus Volar Distal Radius Plate System Submitter: Skeletal Dynamics, LLC 6905 SW 67 Avenue Suite 201 Miami,

More information